Skip to main content

Table 1 Baseline characteristics of participants

From: The significance of the oxidative stress markers in the one-year prognosis of patients with acute ischemic stroke: a case-control study

Variables

Healthy control group (n = 188)

Stroke group (n = 216)

Stroke risk group (n = 152)

Female gender&

96 (51.1%)

68 (31.5%)

64 (42.1%)

Age$ (year)

73.32 (9.43)

71.76 (9.88)

71.89 (10.22)

BMI$ (kg/m2)

26.55 (4.93)

26.92 (5.85)

27.03 (6.33)

Length of Hospitalization$ (day)

ND

11.06 (20.16)

ND

NIHSS-baseline

ND

8.28 (8.90)

ND

NIHSS-follow-up

ND

5.11 (4.86)

ND

MRS- discharge

ND

2.63 (0.78)

ND

MRS- follow-up

ND

1.78 (1.08)

ND

DBP$ (mmHg)

73.62 (9.13)

81.17 (11.92)

87.89 (14.55)

SBP$ (mmHg)

123.09 (14.95)

148.08 (28.02)

150.79 (25.93)

Total cholesterol$ (mg/dl)

167.17 (42.97)

200.06 (62.03)

176.68 (41.58)

Triglyceride$(mg/dl)

119.26 (20.19)

175.20 (91.61)

148.50 (59.29)

LDL$ (mg/dl)

97.81 (26.15)

118.80 (62.58)

111.03 (37.81)

HDL$ (mg/dl)

42.18 (9.31)

46.10 (12.66)

43.36 (13.09)

Serum TAC$ (μmol/L)

3905.98 (879.89)

3687.35 (801.56)

3909.29 (983.87)

Serum MDA$ (μmol/L)

1.85 (0.36)

2.08 (0.24)

1.75 (0.41)

  1. Abbreviations: BMI Body Mass Index, DBP Diastolic Blood Pressure, NIHSS National Institutes of Health Stroke Scale, MRS Modified Rankin Scale, SBP Systolic Blood Pressure, LDL Low-Density Lipoprotein, HDL High-Density Lipoprotein, TAC Total Antioxidant Capacity, MDA Malondialdehyde, ND Not Determined
  2. & Gender is presented as number (percent); there was no significant differences between gender of three group based on Chi-square test (P-value = 0.13)
  3. $ These data are presented as mean (standard deviation)